These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22257707)

  • 41. Rab 23 is expressed in the glomerulus and plays a role in the development of focal segmental glomerulosclerosis.
    Huang TH; Shui HA; Ka SM; Tang BL; Chao TK; Chen JS; Lin YF; Chen A
    Nephrol Dial Transplant; 2009 Mar; 24(3):743-54. PubMed ID: 18927122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Up-Regulation of CD74 Expression in Parietal Epithelial Cells in a Mouse Model of Focal Segmental Glomerulosclerosis.
    Yamazaki T; Sasaki S; Okamoto T; Sato Y; Hayashi A; Ariga T
    Nephron; 2016; 134(4):238-252. PubMed ID: 27463800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The PDE5 inhibitor, vardenafil, ameliorates progressive pathological changes in a focal segmental glomerulosclerosis mouse model.
    Hu SW; Wang YH; Huang JS; Yang YM; Wu CC; Cheng CW
    Life Sci; 2022 Nov; 309():120992. PubMed ID: 36155178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CCR2 antagonism leads to marked reduction in proteinuria and glomerular injury in murine models of focal segmental glomerulosclerosis (FSGS).
    Miao Z; Ertl LS; Newland D; Zhao B; Wang Y; Zang X; Campbell JJ; Liu X; Dang T; Miao S; Krasinski A; Punna S; Zeng Y; McMahon J; Zhang P; Charo IF; Schall TJ; Singh R
    PLoS One; 2018; 13(3):e0192405. PubMed ID: 29561839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events.
    Wang Y; Wang YP; Tay YC; Harris DC
    Kidney Int; 2000 Oct; 58(4):1797-804. PubMed ID: 11012915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal Glomerular Expression of WT-1, TGF-β, VEGF, and ET-1 Immunostains in Murine Models of Focal and Segmental Glomerulosclerosis.
    Husain S
    Appl Immunohistochem Mol Morphol; 2023 Sep; 31(8):574-582. PubMed ID: 37615656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-9 protects from early podocyte injury and progressive glomerulosclerosis in Adriamycin-induced nephropathy.
    Xiong T; Attar M; Gnirck AC; Wunderlich M; Becker M; Rickassel C; Puelles VG; Meyer-Schwesinger C; Wiech T; Nies JF; Divivier M; Fuchs T; Schulze Zur Wiesch J; Taipaleenmäki H; Hoxha E; Wirtz S; Huber TB; Panzer U; Turner JE
    Kidney Int; 2020 Sep; 98(3):615-629. PubMed ID: 32446933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glomerular overproduction of oxygen radicals in Mpv17 gene-inactivated mice causes podocyte foot process flattening and proteinuria: A model of steroid-resistant nephrosis sensitive to radical scavenger therapy.
    Binder CJ; Weiher H; Exner M; Kerjaschki D
    Am J Pathol; 1999 Apr; 154(4):1067-75. PubMed ID: 10233845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absence of gelatinase (MMP-9) or collagenase (MMP-13) attenuates adriamycin-induced albuminuria and glomerulosclerosis.
    Sakamaki Y; Sasamura H; Hayashi K; Ishiguro K; Takaishi H; Okada Y; D'Armiento JM; Saruta T; Itoh H
    Nephron Exp Nephrol; 2010; 115(2):e22-32. PubMed ID: 20407279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells.
    Bao L; Haas M; Pippin J; Wang Y; Miwa T; Chang A; Minto AW; Petkova M; Qiao G; Song WC; Alpers CE; Zhang J; Shankland SJ; Quigg RJ
    J Clin Invest; 2009 May; 119(5):1264-74. PubMed ID: 19349693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resveratrol Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis through C3aR/C5aR- Sphingosine Kinase 1 Pathway.
    Liu G; Wang Q; Shi Y; Peng X; Liu H; Peng Y; He L
    Pharmacology; 2017; 100(5-6):253-260. PubMed ID: 28797008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of calcium(2+)/calmodulin-dependent protein kinase type IV ameliorates experimental nephrotic syndrome.
    Ao Q; Cheng Q; Ma Q; Wang X; Liu S
    Intern Med; 2013; 52(10):1035-41. PubMed ID: 23676587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy.
    Izzedine H; Mangier M; Ory V; Zhang SY; Sendeyo K; Bouachi K; Audard V; Péchoux C; Soria JC; Massard C; Bahleda R; Bourry E; Khayat D; Baumelou A; Lang P; Ollero M; Pawlak A; Sahali D
    Kidney Int; 2014 Feb; 85(2):457-70. PubMed ID: 24067439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experimental focal segmental glomerulosclerosis in mice.
    Chen A; Sheu LF; Ho YS; Lin YF; Chou WY; Chou TC; Lee WH
    Nephron; 1998; 78(4):440-52. PubMed ID: 9578071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mild electrical stimulation with heat shock attenuates renal pathology in adriamycin-induced nephrotic syndrome mouse model.
    Teramoto K; Tsurekawa Y; Suico MA; Kaseda S; Omachi K; Yokota T; Kamura M; Piruzyan M; Kondo T; Shuto T; Araki E; Kai H
    Sci Rep; 2020 Oct; 10(1):18719. PubMed ID: 33128027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TYRO3 agonist as therapy for glomerular disease.
    Zhong F; Cai H; Fu J; Sun Z; Li Z; Bauman D; Wang L; Das B; Lee K; He JC
    JCI Insight; 2023 Jan; 8(1):. PubMed ID: 36454644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-155-5p Aggravates Adriamycin-Induced Focal Segmental Glomerulosclerosis through Targeting Nrf2.
    Liu G; He L; Yang X; Tang L; Shi W; She J; Wei J
    Nephron; 2023; 147(2):108-119. PubMed ID: 35728579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beneficial Effects of Systemically Administered Human Muse Cells in Adriamycin Nephropathy.
    Uchida N; Kushida Y; Kitada M; Wakao S; Kumagai N; Kuroda Y; Kondo Y; Hirohara Y; Kure S; Chazenbalk G; Dezawa M
    J Am Soc Nephrol; 2017 Oct; 28(10):2946-2960. PubMed ID: 28674043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody-induced albuminuria and accelerated focal glomerulosclerosis in the Thy-1.1 transgenic mouse.
    Assmann KJ; van Son JP; Dïjkman HB; Mentzel S; Wetzels JF
    Kidney Int; 2002 Jul; 62(1):116-26. PubMed ID: 12081570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Podocyte-Targeted Treatment for Proteinuric Kidney Disease.
    Mundel P
    Semin Nephrol; 2016 Nov; 36(6):459-462. PubMed ID: 27987545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.